Last reviewed · How we verify

NCT06589193

Comparison of the Clinical and Microbiological Effects of CHX and HOCl Containing Mouthwashes

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing HOCl in Dental Plaque in 26 participants. Completed in 30 September 2022.

Timeline
15 March 2021
Primary endpoint
26 August 2022
30 September 2022

Quick facts

Lead sponsorBaskent University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingquadruple
Primary purposeprevention
Enrollment26
Start date15 March 2021
Primary completion26 August 2022
Estimated completion30 September 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Baskent University

Who can join

Adults 18 to 65, any sex, with Dental Plaque. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of the study is to compare the antiplaque and anti-inflammatory effects of HOCl mouth rinse with those of CHX mouth rinse. The secondary objective is to evaluate and compare the antimicrobial activities of HOCl mouth rinse and CHX mouth rinse on dental biofilm.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Dental Plaque

Currently open trials in the same condition.

Other Baskent University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06589193.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing